PHARMANUTRA SPA (PHN.MI) Stock Fundamental Analysis
Europe - BIT:PHN - IT0005274094 - Common Stock
41.75 EUR
+0.1 (+0.24%)
PHN gets a fundamental rating of 8 out of 10. The analysis compared the fundamentals against 13 industry peers in the Personal Care Products industry. Both the health and profitability get an excellent rating, making PHN a very profitable company, without any liquidiy or solvency issues. PHN is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, PHN could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
PHN had positive earnings in the past year.
In the past year PHN had a positive cash flow from operations.
Each year in the past 5 years PHN has been profitable.
PHN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
PHN has a Return On Assets of 18.91%. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
PHN's Return On Equity of 36.18% is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
The Return On Invested Capital of PHN (23.97%) is better than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PHN is above the industry average of 12.42%.
The last Return On Invested Capital (23.97%) for PHN is above the 3 year average (17.21%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.91% | ||
| ROE | 36.18% | ||
| ROIC | 23.97% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
1.3 Margins
PHN's Profit Margin of 13.77% is fine compared to the rest of the industry. PHN outperforms 76.92% of its industry peers.
PHN's Profit Margin has declined in the last couple of years.
PHN's Operating Margin of 22.67% is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of PHN has remained more or less at the same level.
With an excellent Gross Margin value of 95.55%, PHN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of PHN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.67% | ||
| PM (TTM) | 13.77% | ||
| GM | 95.55% |
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHN is creating value.
The number of shares outstanding for PHN remains at a similar level compared to 1 year ago.
Compared to 5 years ago, PHN has less shares outstanding
PHN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 7.67 indicates that PHN is not in any danger for bankruptcy at the moment.
PHN has a Altman-Z score of 7.67. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
PHN has a debt to FCF ratio of 1.16. This is a very positive value and a sign of high solvency as it would only need 1.16 years to pay back of all of its debts.
PHN has a better Debt to FCF ratio (1.16) than 100.00% of its industry peers.
PHN has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.30, PHN is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 1.16 | ||
| Altman-Z | 7.67 |
ROIC/WACC3.07
WACC7.82%
2.3 Liquidity
A Current Ratio of 2.29 indicates that PHN has no problem at all paying its short term obligations.
PHN has a better Current ratio (2.29) than 92.31% of its industry peers.
A Quick Ratio of 2.02 indicates that PHN has no problem at all paying its short term obligations.
PHN has a Quick ratio of 2.02. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.29 | ||
| Quick Ratio | 2.02 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 29.72% over the past year.
Measured over the past years, PHN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.63% on average per year.
The Revenue has grown by 16.16% in the past year. This is quite good.
The Revenue has been growing by 16.59% on average over the past years. This is quite good.
EPS 1Y (TTM)29.72%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%-8.63%
Revenue 1Y (TTM)16.16%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%11.2%
3.2 Future
PHN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.27% yearly.
The Revenue is expected to grow by 12.23% on average over the next years. This is quite good.
EPS Next Y13.36%
EPS Next 2Y15.1%
EPS Next 3Y14.27%
EPS Next 5YN/A
Revenue Next Year14.66%
Revenue Next 2Y13.77%
Revenue Next 3Y12.23%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
PHN is valuated rather expensively with a Price/Earnings ratio of 17.25.
Based on the Price/Earnings ratio, PHN is valued cheaper than 92.31% of the companies in the same industry.
PHN is valuated rather cheaply when we compare the Price/Earnings ratio to 27.27, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 16.57, PHN is valued correctly.
61.54% of the companies in the same industry are more expensive than PHN, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.77. PHN is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.25 | ||
| Fwd PE | 16.57 |
4.2 Price Multiples
61.54% of the companies in the same industry are more expensive than PHN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHN indicates a somewhat cheap valuation: PHN is cheaper than 76.92% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.53 | ||
| EV/EBITDA | 9.19 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of PHN may justify a higher PE ratio.
A more expensive valuation may be justified as PHN's earnings are expected to grow with 14.27% in the coming years.
PEG (NY)1.29
PEG (5Y)1.18
EPS Next 2Y15.1%
EPS Next 3Y14.27%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.38%, PHN has a reasonable but not impressive dividend return.
PHN's Dividend Yield is comparable with the industry average which is at 2.90.
PHN's Dividend Yield is comparable with the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.38% |
5.2 History
On average, the dividend of PHN grows each year by 11.21%, which is quite nice.
Dividend Growth(5Y)11.21%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
35.05% of the earnings are spent on dividend by PHN. This is a low number and sustainable payout ratio.
The dividend of PHN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP35.05%
EPS Next 2Y15.1%
EPS Next 3Y14.27%
BIT:PHN (9/16/2025, 5:26:17 PM)
41.75
+0.1 (+0.24%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners15.44%
Inst Owner ChangeN/A
Ins Owners65.02%
Ins Owner ChangeN/A
Market Cap404.14M
Analysts83.33
Price Target80.58 (93.01%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.38% |
Yearly Dividend0.85
Dividend Growth(5Y)11.21%
DP35.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.66%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.66%
EPS NY rev (3m)-2.66%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.58%
Revenue NY rev (3m)0.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.25 | ||
| Fwd PE | 16.57 | ||
| P/S | 2.39 | ||
| P/FCF | 19.53 | ||
| P/OCF | 16.26 | ||
| P/B | 6.27 | ||
| P/tB | 9.88 | ||
| EV/EBITDA | 9.19 |
EPS(TTM)2.42
EY5.8%
EPS(NY)2.52
Fwd EY6.04%
FCF(TTM)2.14
FCFY5.12%
OCF(TTM)2.57
OCFY6.15%
SpS17.49
BVpS6.66
TBVpS4.22
PEG (NY)1.29
PEG (5Y)1.18
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.91% | ||
| ROE | 36.18% | ||
| ROCE | 41.7% | ||
| ROIC | 23.97% | ||
| ROICexc | 35.83% | ||
| ROICexgc | 57.7% | ||
| OM | 22.67% | ||
| PM (TTM) | 13.77% | ||
| GM | 95.55% | ||
| FCFM | 12.22% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
ROICexc(3y)25.61%
ROICexc(5y)33.67%
ROICexgc(3y)43.23%
ROICexgc(5y)50.61%
ROCE(3y)29.76%
ROCE(5y)31.61%
ROICexcg growth 3Y-15.98%
ROICexcg growth 5Y-10.26%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y-11.75%
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
F-Score8
Asset Turnover1.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 1.16 | ||
| Debt/EBITDA | 0.46 | ||
| Cap/Depr | 106.2% | ||
| Cap/Sales | 2.46% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.76% | ||
| Profit Quality | 88.74% | ||
| Current Ratio | 2.29 | ||
| Quick Ratio | 2.02 | ||
| Altman-Z | 7.67 |
F-Score8
WACC7.82%
ROIC/WACC3.07
Cap/Depr(3y)763.09%
Cap/Depr(5y)544.05%
Cap/Sales(3y)14.97%
Cap/Sales(5y)11.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.72%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%-8.63%
EPS Next Y13.36%
EPS Next 2Y15.1%
EPS Next 3Y14.27%
EPS Next 5YN/A
Revenue 1Y (TTM)16.16%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%11.2%
Revenue Next Year14.66%
Revenue Next 2Y13.77%
Revenue Next 3Y12.23%
Revenue Next 5YN/A
EBIT growth 1Y19.75%
EBIT growth 3Y13.47%
EBIT growth 5Y17.77%
EBIT Next Year24.88%
EBIT Next 3Y16.72%
EBIT Next 5Y9.17%
FCF growth 1Y235.79%
FCF growth 3Y1.75%
FCF growth 5Y17.94%
OCF growth 1Y134.99%
OCF growth 3Y0.14%
OCF growth 5Y11.34%